Tuberculosis among drug users and homeless persons: Impact of voluntary X-ray investigation on active case finding

Infection

Volumn 40, Issue 4, 2012, Pages 389-395

  Goetsch, U ^a   Bellinger, O K ^a   Buettel, K L ^a   Gottschalk, R ^a  

^a Health Protection Authority   (Germany)

Author keywords

Homeless persons; Human immunodeficiency virus; Illicit drug users; Screening programme; Tuberculosis

Indexed keywords

ILLICIT DRUG;

ADULT; ARTICLE; CASE FINDING; CLINICAL ARTICLE; CONTACT EXAMINATION; DRUG USE; FEMALE; FOLLOW UP; HEALTH PROGRAM; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LUNG TUBERCULOSIS; MALE; MIXED INFECTION; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; SCREENING; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS CONTROL;

ADULT; DRUG USERS; FEMALE; HOMELESS PERSONS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; RADIOGRAPHY, THORACIC; RISK FACTORS; TUBERCULOSIS;

EID: 84866732092     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0238-x     Document Type: Article

References (36)

1. Hayward AC, Darton T, Van-Tam JN, Watson JM, Coker R, Schwoebel V. Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis. 2003;7(8):751-7.
2. Moore-Gillon J. Tuberculosis and poverty in the developed world. PD D: Chapman and Hall; 1998.
3. Hopewell PC. Targeting tuberculosis prevention. Am J Respir Crit Care Med. 2000;162(6):2017-8.
4. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, et al. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000. Am J Respir Crit Care Med. 2008;177(3):348-55.
5. Moonan PK, Weis SE. Assessing the impact of targeted tuberculosis interventions. Am J Respir Crit Care Med. 2008;177(5):557-8.
6. Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax. 2007;62(8):667-71.
7. Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M. Tuberculosis and homelessness in the United States, 1994-2003. JAMA. 2005;293(22):2762-6.
8. Pablos-Mendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med. 1997;102(2):164-70.
9. Diel R, Schneider S, Meywald-Walter K, Ruf CM, Rusch-Gerdes S, Niemann S. Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol. 2002;40(2):532-9.
10. Conover C, Ridzon R, Valway S, Schoenstadt L, McAuley J, Onorato I, et al. Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis. 2001;5(1):59-64.
11. Curtis AB, Ridzon R, Novick LF, Driscoll J, Blair D, Oxtoby M, et al. Analysis of Mycobacterium tuberculosis transmission patterns in a homeless shelter outbreak. Int J Tuberc Lung Dis. 2000;4(4):308-13.
12. Story A, van Hest R, Hayward A. Tuberculosis and social exclusion. Br Med J. 2006;333(7558):57-8.
13. Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA. 2002;287(8):991-5.
14. de Vries G, van Hest RA. From contact investigation to tuberculosis screening of drug addicts and homeless persons in Rotterdam. Eur J Public Health. 2006;16(2):133-6.
15. Li J, Driver CR, Munsiff SS, Fujiwara PI. Finding contacts of homeless tuberculosis patients in New York City. Int J Tuberc Lung Dis. 2003;7[12 Suppl 3]:S397-404.
16. Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med. 2000;160(5):697-702.
17. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest. 1997;111(5):1168-73.
18. Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, et al. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8(11):1280-4.
19. Daley CL, Hahn JA, Moss AR, Hopewell PC, Schecter GF. Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy. Am J Respir Crit Care Med. 1998;157(1):19-22.
20. Southern A, Premaratne N, English M, Balazs J, O'Sullivan D. Tuberculosis among homeless people in London: an effective model of screening and treatment. Int J Tuberc Lung Dis. 1999;3(11):1001-8.
21. Keizer ST, Langendam MM, van Deutekom H, Coutinho RA, van Ameijden EJ. How does tuberculosis relate to HIV positive and HIV negative drug users? J Epidemiol Community Health. 2000;54(1):64-8.
22. Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Lod-denkemper R, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002;19(4):765-75.
23. Bales S, Baumann HG, Schnitzler N. Infektionsschutzgesetz. 2 edn. Stuttgart: W. Kohlhammer GmbH; 2003.
24. Diel R, Forssbohm M, Loytved G, Haas W, Hauer B, Maffei D, et al. Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis. Gesundheitswesen. 2007;69(8-9):488-503.
25. Chao A. Estimating the population size for capture-recapture data with unequal catchability. Biometrics. 1987;43(4):783-91.
26. Rendleman NJ. Mandated tuberculosis screening in a community of homeless people. Am J Prev Med. 1999;17(2):108-13.
27. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med. 1996;156(2):161-5.
28. Solsona J, Cayla JA, Nadal J, Bedia M, Mata C, Brau J, et al. Screening for tuberculosis upon admission to shelters and free-meal services. Eur J Epidemiol. 2001;17(2):123-8.
29. Snyder DC, Paz EA, Mohle-Boetani JC, Fallstad R, Black RL, Chin DP. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness. Am J Respir Crit Care Med. 1999;160(1):178-85.
30. Van Hest NA, De Vries G, Smit F, Grant AD, Richardus JH. Estimating the coverage of a targeted mobile tuberculosis screening programme among illicit drug users and homeless persons with truncated models. Epidemiol Infect. 2008;136(5):628-35.
31. van Asten L, Langendam M, Zangerle R, Hernandez Aguado I, Boufassa F, Schiffer V, et al. Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion. Aids. 2003;17(8):1201-8.
32. Cayla JA, Garcia de Olalla P, Galdos-Tanguis H, Vidal R, Lopez-Colomes JL, Gatell JM, et al. The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. Aids. 1996;10(12):1446-7.
33. Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med. 2000;162(2 Pt 1):460-4.
34. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979;139(3):337-9.
35. Frankfurt Co. Statistisches Jahrbuch. Amt für Statistik: Frankfurt; 2007.
36. Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, et al. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med. 2001;110(8):610-5.